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Azoospermia in men requires microsurgical reconstruction or a procedure for sperm retrieval with assisted
reproduction to allow fertility. While the chance of successful retrieval of sperm in men with obstructive
azoospermia approaches >90%, the chances of sperm retrieval in men with non-obstructive azoospermia (NOA) are
not as high. Conventional procedures such as fine needle aspiration of the testis, testicular biopsy and testicular
sperm extraction are successful in 20-45% of men with NOA. With microdissection testicular sperm extraction
(micro-TESE), the chance of successful retrieval can be up to 60%. Despite this increased success, the ability to
counsel patients preoperatively on their probability of successful sperm retrieval has remained challenging. A
combination of variables such as age, serum FSH and inhibin B levels, testicular size, genetic analysis, history of
Klinefelter syndrome, history of cryptorchidism or varicocele and histopathology on diagnostic biopsy have
provided some insight into the chance of successful sperm retrieval in men with NOA. The goal of this review was
to evaluate the preoperative factors that are currently available to predict the outcome for success with micro-TESE.
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Pour permettre une fécondité chez l’homme, l’azoospermie nécessite une reconstruction par microchirurgie ou une
procédure de récupération de spermatozoïdes avec assistance médicale à la procréation. Alors que les chances
d’une extraction positive de spermatozoïdes chez les hommes qui présentent une azoospermie obstructive
atteignent plus de 90%, ces chances ne sont pas aussi grandes chez les hommes qui ont une azoospermie non
obstructive (NOA). Les procédures conventionnelles telles que l’aspiration à l’aiguille fine du testicule, la biopsie
testiculaire et l’extraction testiculaire de spermatozoïdes sont couronnées de succès chez 20-45% des hommes avec
NOA. En cas d’extraction de spermatozoïdes testiculaires par microdissection (micro-TESE), les chances d’un
prélèvement positif peuvent aller jusqu’à 60%. Malgré cette augmentation des chances, la possibilité d’informer les
patients avant l’intervention de leurs chances d’avoir un prélèvement de spermatozoïdes positif reste un défi. La
combinaison de variables telles l’âge, les taux sériques de FSH et d’inhibine B, le volume testiculaire, les analyses
génétiques, un antécédent de syndrome de Klinefelter, de cryptorchidie ou de varicocèle, et l’histopathologie du
tissu recueilli lors d’une biopsie diagnostique, a fourni un aperçu des chances d’obtenir un prélèvement positif de
spermatozoïdes chez les hommes avec NOA. L’objectif de cette revue est d’évaluer les facteurs préopératoires qui
sont actuellement disponibles pour prédire une issue positive à une micro-TESE.
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Table 1 Overview of preoperative factors considered for




Serum FSH FSH, although a good predictor of global
testicular function, does not serve by itself as a
predictor of successful micro-TESE, but models
have shown some predictive value when used in
conjunction with other variables [14,19-22]
Serum Inhibin B Inhibin B, like FSH, does not serve as a good
predictor of micro-TESE by itself, but models have
shown predictive value when used in conjunction
with other variables [15,19]
Histopathology Histopathology is likely the greatest single
predictor of successful micro-TESE, but the
requirement of a separate surgical procedure for
diagnosis makes its role very limited [35,59]
Testicular volume The data on testicular volume and its predictive
value for micro-TESE is limited, and suggests that
it is not a good predictive variable for micro-TESE
[36,37]
Genetics Genetics, particularly Y chromosome
microdeletions, are very helpful in predicting
success of micro-TESE; men with AZFc
microdeletions have very good chance of
successful micro-TESE, whereas those men with




Men with KS have successful micro-TESE rates
similar to or better than all men with NOA, and
KS itself is a good prognostic factor for sperm
retrieval [43,45]
Age While advanced paternal age may play a role in
decreased pregnancy rates, the limited studies
thus far show that it does not play a predictive
role for micro-TESE (unpublished data)
Cryptorchidism Men with a history of cryptorchidism have
successful micro-TESE rates to men without
cryptorchidism, suggesting that it does not play a
predictive role in the success of micro-TESE [50]
Varicocele The need for varicocelectomy in men with a
varicocele and NOA prior to micro-TESE is
debated, but men with a clinical varicocele who
undergo varicocelectomy prior to micro-TESE
have higher sperm retrieval rates compared to
men with all other causes of NOA, suggesting
that varicocele repair is a positive prognostic
factor for men undergoing micro-TESE [55,57,58]
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Men undergoing evaluation for infertility are found to
have azoospermia, or lack of sperm in the ejaculate, up
to 10% of the time [1]. Approximately 60% of these cases
are due to non-obstructive azoospermia (NOA) [2] a
condition in which men have impaired production of
sperm. Men with NOA require some form of sperm re-
trieval procedure in conjunction with intra-cytoplasmic
sperm injection (ICSI) [3] to father their own children.
Microdissection testicular sperm extraction (Micro-TESE),
currently one of the most popular sperm retrieval proce-
dures for men with NOA, was first described in 1999.
Micro-TESE provides the advantage of allowing the sur-
geon to selectively identify seminiferous tubules most
likely to contain spermatozoa based on the larger and
more opaque appearance of those tubules. With micro-
TESE, successful sperm retrieval has been reported in
men up to 63% of men [4], whereas conventional and
more limited sperm retrieval procedures have reported
success rates from 20% (percutaneous testicular biopsies)
[5] to 45% (open testis biopsies) [6]. Studies formally com-
paring conventional testicular sperm extraction (TESE) vs.
micro-TESE have seen similar results, with sperm retrieval
rates significantly higher when the procedure is performed
with a microsurgical approach [7,8].
The technique for performing micro-TESE was ori-
ginally described by Schlegel [6]. The procedure is ini-
tially performed under 6-8x magnification to optimize
visualization of blood vessels and allow for a wide in-
cision in the tunica albuginea in an avascular plane.
Next, the magnification is increased to 15-20x for iden-
tification of larger individual seminiferous tubules that
are more opaque than other surrounding tubules. These
tubules are then cut into small pieces to release sperm-
atozoa from the tubules. Finally, this processed sample
is examined for viable spermatozoa [8].
While the success of micro-TESE compared to other
sperm retrieval techniques has been widely accepted, a full
understanding of predicting preoperatively whom the pro-
cedure is going to be successful is not entirely clear and re-
mains controversial [9]. Several studies have analyzed
preoperative variables used to predict sperm retrieval with
conventional procedures [10-13]. In this review, we will
evaluate preoperative variables such as age, FSH, testicular
volume, inhibin B, genetics, Klinefelter syndrome, history
of varicocele, cryptorchidism, as well as intraoperative vari-
ables such as histopathology and tubular diameter and
their relevance for predicting the outcome of micro-TESE.
These variables were determined by reviewing the available
literature on prediction of success in sperm retrieval tech-
niques, with a focus on those reviews that are dedicated to
micro-TESE. Table 1 summarizes all of these factors and
their role in prediction of sperm retrieval during micro-
TESE.Follicle-stimulating hormone (FSH)
Follicle-stimulating hormone (FSH) is a glycoprotein pro-
duced in the pituitary gland after stimulation by GnRH
from the hypothalamus. It exerts its action by binding to
receptors on Sertoli cells in the testes leading to produc-
tion of hormones (eg. inhibin and activin) and nutrients
required for germ cell maturation [14]. Because of this
mechanism of action, many have theorized that FSH may
be useful in predicting the outcome of sperm retrieval
procedures, in that patients with very high levels of FSH
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within the testis.
FSH levels differ significantly in patients with whom
sperm is retrieved vs. patients where sperm is not retrieved
with conventional TESE [15,16], and azoospermic men
with high FSH have been shown to have lower sperm re-
trieval rates [17]. Some have advocated that exogenous ad-
ministration of recombinant FSH can increase the success
of sperm retrieval when such treatment is given prior to a
sperm retrieval procedure [18]. In a study by Aydos et al.
108 men with NOA and normal FSH levels were included
in the study. The study population received pure FSH
three times per week for three months (vs control group
that received no treatment) followed by micro-TESE. Men
who received therapy with pure FSH were almost twice as
likely to have sperm retrieved during their procedure (64%
vs. 33% sperm retrieval rates in the treatment group com-
pared to the control group) despite a lack of change in
FSH levels for treated men. Tsujimura et al. have reported
that preoperative serum FSH level in combination with
other factors may help predict the success of micro-TESE
[19]. These findings would suggest a predictive role of
serum FSH is used to project the outcome of sperm re-
trieval, and suggest a potential therapeutic role for increas-
ing sperm production prior to performing a procedure.
Despite these outlier studies, a majority of evaluations
have shown that the predictive value of FSH for success
of TESE and other sperm retrieval methods is either low
or non-existent [20-23]. With regards to micro-TESE,
we have previously shown that men with high FSH have
similar or better sperm retrieval compared to those with
lower FSH [24,25]. In fact, a subset of men with normal
FSH levels could have a uniform histological pattern of
maturation arrest and extremely poor sperm retrieval rates
[26]. These apparent discrepancies can be explained by
the fact that FSH serves as an indicator of overall testicular
function, as suggested by previous studies showing the
connection between elevated FSH levels and poor histo-
logical features and lower sperm retrieval rates with
testicular biopsy [24,27]. So, while FSH is believed to be
related to the number of germ cells present in the testicle,
a high FSH level may not reflect the relatively few semin-
iferous tubules that could contain sperm [4,28]. Because
micro-TESE allows the surgeon to find areas of advanced
spermatogenesis in the testicle, successful sperm retrieval
is still possible in men with high FSH. High and abnormal
FSH levels should not be considered a contraindication
for micro-TESE in experienced hands.
Inhibin B
Inhibin B is a glycoprotein hormone produced by Sertoli
cells in the testicle. It acts as a negative regulatory factor
on FSH and subsequently is found to be low in men with
testicular dysfunction and low levels of spermatogenesis[29]. Because of this, inhibin B has been found to correlate
well with the degree of spermatogenesis seen on histologic
analysis that occurs in the testicle [30]. Similar to the find-
ings seen with FSH, there is a significant difference in the
level of inhibin B seen in men who successfully undergo
conventional TESE vs. those that do not have sperm
retrieved [15].
Because of these findings, it was thought that inhibin
B would prove to be a valuable marker for success of
sperm retrieval. Several studies have shown that inhibin
B may have a role in providing an accurate prediction
with respect to sperm retrieval [31,32]. Bohring et al.
reported a sensitivity and specificity approaching 80%
for inhibin B with respect to prediction of histologic
features in the testicle, although the sensitivity and specifi-
city of this marker both dropped to less than 50% when
attempting to predict sperm retrieval [31]. Ballesca et al.
found that inhibin B levels were predictive of TESE out-
come with a sensitivity of 90% and specificity of 100%
when comparing men with nonobstructive azoospermia
to those with either obstructive azoospermia or normal
semen analysis [32]. Similar to FSH, inhibin B has also
been found to be a predictive factor for outcome of
micro-TESE, but only when combined with other vari-
ables in predictive models of micro-TESE [19].
Despite these findings, a majority of studies refute
the notion that inhibin B is a predictive marker at all
[10,20,33,34]. Tunc et al. found no difference in inhibin
B levels in patients with a successful vs. unsuccessful
TESE procedure, with specificity as low as 14% [10].
Vernaeve et al. found similar results, once again with
no difference in inhibin B levels in men with a successful
vs. unsuccessful TESE procedure.
These contradictory findings have made the role of in-
hibin B as a predictive marker controversial, but the ma-
jority of findings suggest that it remains a poor predictive
marker for micro-TESE outcome. In conjunction with
other preoperative markers it could have a small predictive
value, but we do not utilize it as a routine evaluation tool
in men with NOA prior to micro-TESE.
Testis volume
Larger testes have often been considered a sign of normal
spermatogenesis. Small and atrophic testicles are seen in
many men with nonobstructive azoospermia. Schoor et al.
defined that men with a testicular long axis of 4.6 cm or
less as well as an FSH of 7.6 mIU/mL or less are likely to
have nonobstructive azoospermia based on these factors
alone [35].
While this may be the case, the use of testicular size
alone to predict outcome is very limited. While there
has been shown to be a positive correlation between tes-
ticular volume and both success in conventional TESE
and sperm aspiration [15] as well as micro-TESE [19], it
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variable [36]. In our analysis, testicular volume played no
role in the ability to successfully predict outcome of
micro-TESE [37]. Similar to FSH, while small testicles may
represent a global pattern of poor spermatogenesis, testis
volume may not predict the relatively rate tubules with
spermatogenesis that could be identified with micro-TESE.
Testis size still remains to be a poor predictor of success-
ful sperm retrieval outcome [37].
Genetics
Microdeletions that occur on the Y chromosome, specific-
ally in the AZFa, AZFb and AZFc regions have been deter-
mined to provide valuable prognostic information about
the chance of sperm retrieval. According to the American
Urological Association guidelines, men presenting with
infertility found to have nonobstructive azoospermia
or severe oligospermia (<5 million/ml) should undergo
karyotype and Y-chromosome microdeletion testing [38].
Microdeletions in AZFa and AZFb provide a worse
prognosis, and no man has been reported to have re-
trievable sperm [39]. Isolated AZFa deletions, while rare,
are associated with a Sertoli cell-only histologic pattern
with no sperm [40], and AZFb deletions are most often
seen in conjunction with at least focal maturation arrest
[39]. Because of these observations, micro-TESE is con-
traindicated in patients found to have either complete
AZFa or AZFb microdeletions. Patients with deletions in
the AZFc region, the most common microdeletion seen,
either have rare sperm in the ejaculate or are often able
to have successful sperm retrieval with micro-TESE [6].
Stahl et al. examined 149 patients with microdeletions
and found that the sperm retrieval rate was 71.4% in
men with AZFc deletions, but that there was no sperm
retrieved in any men with AZFa, AZFb, AZFb + c or
complete Yq deletions [41].
The use of genetic testing for Y chromosome micro-
deletions in men with nonobstructive azoospermia
remains critical, and should be routinely used prior to
micro-TESE.
Klinefelter syndrome
Klinefelter syndrome (KS) is the most common genetic
abnormality seen in men with infertility. Men with non-
mosaic KS are azoospermic, therefore not able to produce
viable pregnancies without assisted reproductive technolo-
gies [42,43]. Men with non-mosaic KS have a favorable
success with micro-TESE. Several studies have evaluated
preoperative factors such as testis volume, serum testos-
terone and human chorionic gonadotropin (hCG) [13,44]
to predict successful sperm retrieval in men with KS and
have had varying results.
In our experience, there was no predictive value of
serum FSH, LH or testis volume for sperm retrieval inpatients with KS [45]. Sperm were successfully retrieved
in 68% of this cohort, slightly greater than most reported
retrieval rates with micro-TESE. Interestingly men with
normal testosterone levels (>300 ng/dL) had up to 85%
chance of successful sperm retrieval. In addition, men with
who responded to preoperative therapy with clomiphene
citrate, aromatase inhibitors, HCG or a combination of
these hormonal interventions with increased serum testos-
terone levels to ≥ 250 ng/dL had a higher sperm retrieval
rate (SRR) than men who did not respond.
Age
Advanced paternal age has been considered as a possible
factor that could contribute to the success of sperm
retrieval procedures, with the suggestion that as men
age, the areas of active spermatogenesis would decrease.
It is not known whether older men have more azoosper-
mia than younger men. Studies on paternal age and its
effect on fertility are limited and no specific male cut-off
age where fertility is negatively affected has been defined
[46,47]. Despite this, there has been a suggestion that
advanced paternal age leads to lower pregnancy rates
and live birth rates, at least when men are age 45-50 or
older [48,49]. We found no association between male
age and outcome of micro-TESE, and the overall sperm
retrieval rate was actually highest in men 40 years or
older and we found no upper limit for male age at which
micro-TESE was successful (unpublished data).
Cryptorchidism
We have previously shown that men with cryptorchidism
had a good chance of sperm retrieval when undergoing
micro-TESE [37,50]. In fact, cryptorchid men tended to
have slightly higher sperm retrieval rates (74%) relative to
all other men with nonobstructive azoospermia (58%),
although the difference in pregnancy rates was not statisti-
cally significant. In men with cryptorchidism, there was a
correlation with both testicular volume and age at
orchiopexy, whereas these associations were not seen in
the entire cohort of men with nonosbtructive azoosper-
mia. These results are similar to other series of men with
cryptorchidism and nonobstructive azoospermia [51] in-
cluding men who have undergone bilateral orchidopexy
[52], suggesting that these men have a good chance of
successful sperm recovery with micro-TESE.
Varicocele
Varicoceles in men often lead to poor sperm quality as
well as azoospermia [53]. For that reason, many men
with a varicocele and azoospermia will undergo a vari-
cocele repair prior to attempts at surgical sperm re-
trieval in the hopes of obtaining sperm in the ejaculate.
Varicocelectomy for NOA however still remains contro-
versial. Schlegel and Goldstein outlined several of the
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pair, including low testosterone, prevention of progressive
testicular dysfunction, testicular pain and nonobstructive
azoospermia [54]. There have been reports suggested in-
creased sperm production in over half of patients leading
to detectable sperm in the ejaculate after varicocelectomy
in men with azoospermia [55], as well as reports of ad-
equate sperm in the ejaculate after varicocelectomy in
as few as 10% of patients [56]. Similarly, there have been
both reports of improved sperm retrieval rates after
varicocelectomy prior to micro-TESE in patients with
nonobstructive azoospermia with a clinical varicocele
[57], as well as reports suggesting that the varicocelectomy
in these patients does not improve outcomes of micro-
TESE [56]. Because of these conflicting results, the need
for varicocelectomy in men prior to micro-TESE for
sperm retrieval remains controversial. Haydardedeoglu et
al compared men who had NOA and a clinical varicocele
to men with NOA and no varicocele. They found that the
men with a varicocele whom underwent varicocelectomy
had higher rates of sperm retrieval compared to men with
NOA and no varicocele [58], suggesting that the repair of
a varicocele in men with NOA may play a predictive role
in success of micro-TESE.
Histopathology
Perhaps the strongest predictor of successful sperm re-
trieval is testicular histopathology. Many of the patients
that are seen at a large tertiary referral center have had
previous fertility counseling or procedures, and it is
often helpful to include this data when counseling these
patients on their chance of success with micro-TESE.
For example, a patient may be seen who has had a tes-
ticular biopsy in the past, and because of this his histo-
pathology is known. While many practitioners would
not have done or recommended this procedure, the data
is available and it is a useful piece of information that
can be utilized.
When examining the histology of sperm retrieval
specimens, the pattern seen can often be suggestive of
the production of sperm. It is important to consider
whether the histologic pattern analyzed was the most
advanced pattern of histology, or the predominant
histologic pattern, as the two analyses can provide very
different information regarding the patient or testis be-
ing described. It has been shown that men with just
Sertoli cell-only syndrome (SCO) have a much lower
rate of spermatozoa recovery when compared to men
with predominantly hypospermatogenesis (HS) and
maturation arrest (MA) [21]. Histopathologic specimen
alone has been shown to be the strongest single pre-
dictor of successful sperm retrieval with conventional
techniques [59]. In micro-TESE performed on patients
with Klinefelter syndrome, no single preoperativepredictive variable was noted to predict a successful out-
come, but there were several variables where an associ-
ation was noted. Men with Sertoli cell-only on diagnostic
biopsy had a sperm retrieval rate of 70%, and the presence
of seminiferous tubules that did not have sclerotic changes
during the procedure was associated with the most favor-
able outcomes [60].
Because histopathology is now usually examined at the
time of sperm retrieval and is not typically a preoperative
variable, it can be used to determine success of sperm
retrieval only if a diagnostic biopsy was performed. One
such way would be the use of testicular biopsies before a
more definitive sperm retrieval is performed. The use of
histopathology on testicular biopsy has been shown to
have some benefit, with the predictive value of biopsy ap-
proaching 90% if a spermatozoon is seen when examining
the biopsy specimen [61]. The finding of mature sperm-
atozoa upon examination of the histopathologic specimen
provides the greatest positive predictor for success of
sperm retrieval [62]. Thus, testicular biopsy findings may
provide the most accurate predictor of successful sperm
retrieval, when positive, but of limited value – the vast
majority of cases – when negative [35].
Despite this promising predictive value of biopsy find-
ings, the performance of a biopsy on all patients before
undergoing a sperm retrieval procedure is not necessar-
ily desirable. The biopsy itself is a procedure with varied
complications including post-procedural pain, infection,
devascularization and bleeding leading to hematoma for-
mation. Along with this, many patients will still go on to
have a sperm retrieval procedure despite the biopsy find-
ings unless it is a planned therapeutic biopsy.
Conclusions
There is no individual characteristic or variable that can
accurately predict the ability to retrieve sperm during a
surgical procedure. While preoperative variables still do
not provide a perfect model to predict success of micro-
TESE, current research suggests that a combination of
these variables can be used to counsel patients and help
guide clinical decisions. More genetic, molecular and
imaging studies are needed specifically on the prediction
of outcomes of sperm retrieval in men with NOA to de-
termine the most efficient way to guide clinicians when
counseling their patients on the probability of success
with micro-TESE.
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